Andrew W Munro

Prof. Andrew W Munro


Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2002 in Trends in Biochemical Sciences
Verified
Journal Article
Closed access
AMAndrew W Munro
Andrew W Munro
DLDavid G Leys
David G Leys
KMKirsty J McLean
Kirsty J McLean
KMKer R Marshall
Ker R Marshall
TOTobias W.B Ost
Tobias W.B Ost
PDP.LEslie Dutton
P.LEslie Dutton

1 June 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
FGFrederick Peter Guengerich
Frederick Peter Guengerich
AMAndrew W Munro
Andrew W Munro
Cytochrome P450 enzymes primarily catalyze mixed-function oxidation reactions, plus some reductions and rearrangements of oxygenated species, e.g. prostaglandins. Most of these reactions can be rationalized in a paradigm involving Compound I, a high-valent iron-oxygen complex (FeO(3+)), to explain seemingly unusual reactions, including ring couplings, ring expansion and contraction, and fusion of substrates. Most P450s interact with flavoenzymes or iron-sulfur proteins to receive electrons from NAD(P)H. In some cases, P450s are fused to protein partners. Other P450s catalyze non-redox isomerization reactions. A number of permutations on the P450 theme reveal the diversity of cytochrome P450 form and function.

4 May 2007 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
AMAndrew W Munro
Andrew W Munro
HGHazel M Girvan
Hazel M Girvan
KMKirsty J McLean
Kirsty J McLean
Covering: up to the end of 2006 The catalytic potential of the P450s in organic biotransformations is the subject of this review—with emphasis on the breadth of P450 redox systems now recognised and the catalytic versatility of these biotechnologically important enzymes.

1 April 2016 in Current Opinion in Chemical Biology
Verified
Journal Article
Open access
HGHazel M Girvan
Hazel M Girvan
AMAndrew W Munro
Andrew W Munro
Cytochrome P450 enzymes (P450s) are a superfamily of monooxygenase enzymes with enormous potential for synthetic biology applications. Across Nature, their substrate range is vast and exceeds that of other enzymes. The range of different chemical transformations performed by P450s is also substantial, and continues to expand through interrogation of the properties of novel P450s and by protein engineering studies. The ability of P450s to introduce oxygen atoms at specific positions on complex molecules makes these enzymes particularly valuable for applications in synthetic biology. This review focuses on the enzymatic properties and reaction mechanisms of P450 enzymes, and on recent studies that highlight their broad applications in the production of oxychemicals. For selected soluble bacterial P450s (notably the high-activity P450-cytochrome P450 reductase enzyme P450 BM3), variants with a multitude of diverse substrate selectivities have been generated both rationally and by random mutagenesis/directed evolution approaches. This highlights the robustness and malleability of the P450 fold, and the capacity of these biocatalysts to oxidise a wide range of chemical scaffolds. This article reviews recent research on the application of wild-type and engineered P450s in the production of important chemicals, including pharmaceuticals and drug metabolites, steroids and antibiotics. In addition, the properties of unusual members of the P450 superfamily that do not follow the canonical P450 catalytic pathway are described.

6 February 2018 in Biochemical Society Transactions
Verified
Journal Article
Open access
PDF file
AMAndrew W Munro
Andrew W Munro
KMKirsty J McLean
Kirsty J McLean
JGJob L. Grant
Job L. Grant
TMThomas M. Makris
Thomas M. Makris
The cytochromes P450 (P450s or CYPs) constitute a large heme enzyme superfamily, members of which catalyze the oxidative transformation of a wide range of organic substrates, and whose functions are crucial to xenobiotic metabolism and steroid transformation in humans and other organisms. The P450 peroxygenases are a subgroup of the P450s that have evolved in microbes to catalyze the oxidative metabolism of fatty acids, using hydrogen peroxide as an oxidant rather than NAD(P)H-driven redox partner systems typical of the vast majority of other characterized P450 enzymes. Early members of the peroxygenase (CYP152) family were shown to catalyze hydroxylation at the α and β carbons of medium-to-long-chain fatty acids. However, more recent studies on other CYP152 family P450s revealed the ability to oxidatively decarboxylate fatty acids, generating terminal alkenes with potential applications as drop-in biofuels. Other research has revealed their capacity to decarboxylate and to desaturate hydroxylated fatty acids to form novel products. Structural data have revealed a common active site motif for the binding of the substrate carboxylate group in the peroxygenases, and mechanistic and transient kinetic analyses have demonstrated the formation of reactive iron-oxo species (compounds I and II) that are ultimately responsible for hydroxylation and decarboxylation of fatty acids, respectively. This short review will focus on the biochemical properties of the P450 peroxygenases and on their biotechnological applications with respect to production of volatile alkenes as biofuels, as well as other fine chemicals.

1 March 2007 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
AMAndrew W Munro
Andrew W Munro
HGHazel M Girvan
Hazel M Girvan
KMKirsty J McLean
Kirsty J McLean